Smith Shadomy
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 56
- Antimicrobial Resistance in Staphylococcus 13
- Epidemiology top 1%
- Fungal Infections and Studies 35
- Nail Diseases and Treatments 32
- Small Animals top 1%
- Cell Biology top 5%
- Plant Pathogens and Fungal Diseases 12
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 17
-
- Antibiotic Resistance in Bacteria 16
-
- Bacterial Identification and Susceptibility Testing 6
- Co-authors
- Ana Espinel-IngroffH. Jean ShadomyAna Espinel‐IngroffThomas M. KerkeringWilliam E. DismukesDennis M. DixonJohn F. FisherRobert B. Diasio
- Journals
- Antimicrobial Agents and Chemotherapy (22 papers)Journal of Clinical Microbiology (7 papers)Medical Mycology (6 papers)
- Partner nations
- United States
In The Last Decade
Smith Shadomy
102 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 113
- Infectious Diseases 2.0k
- Epidemiology 1.9k
- Small Animals 292
- Cell Biology 435
- Pharmacology 377
Countries citing papers authored by Smith Shadomy
This map shows the geographic impact of Smith Shadomy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smith Shadomy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smith Shadomy more than expected).
Fields of papers citing papers by Smith Shadomy
This network shows the impact of papers produced by Smith Shadomy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smith Shadomy. The network helps show where Smith Shadomy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Smith Shadomy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 4 | |
| 2 | 1990 | 45 | |
| 3 | 1989 | 125 | |
| 4 | 1988 | 4 | |
| 5 | 1986 | 12 | |
| 6 | 1981 | 13 | |
| 7 | 1979 | 3 | |
| 8 | 1978 | 3 | |
| 9 | 1978 | 18 | |
| 10 | 1978 | 16 | |
| 11 | 1977 | 4 | |
| 12 | 1974 | 2 | |
| 13 | 1971 | 64 | |
| 14 | 1969 | 4 | |
| 15 | In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine. | 1968 | 44 |
| 16 | 1966 | 3 | |
| 17 | 1965 | 13 | |
| 18 | 1965 | 18 | |
| 19 | 1965 | 5 | |
| 20 | 1957 | 1 |
About Smith Shadomy
Smith Shadomy is a scholar working on Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology, Epidemiology and Endocrinology, having authored 108 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (56 papers), Fungal Infections and Studies (35 papers), Nail Diseases and Treatments (32 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers), Antibiotic Resistance in Bacteria (16 papers), Antimicrobial Resistance in Staphylococcus (13 papers), Plant Pathogens and Fungal Diseases (12 papers) and Bacterial Identification and Susceptibility Testing (6 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Epidemiology (1.9k citations), Small Animals (292 citations), Cell Biology (435 citations) and Pharmacology (377 citations). Smith Shadomy has collaborated with scholars based in United States. Frequent co-authors include Ana Espinel-Ingroff, H. Jean Shadomy, Ana Espinel‐Ingroff, Thomas M. Kerkering, William E. Dismukes, Dennis M. Dixon, John F. Fisher, Robert B. Diasio, Richard J. Duma and Frances M. Keddie. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Medical Mycology, The Journal of Infectious Diseases and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.